✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › BENZIMIDAVIR

BENZIMIDAVIR

CAS 176161-24-3C15H19Cl2N3O4MW 376.2

BENZIMIDAVIR (CAS 176161-24-3) — formula C15H19Cl2N3O4, molecular weight 376.2.

Product Overview

CAS Number176161-24-3
Molecular FormulaC15H19Cl2N3O4
Molecular Weight376.2
LogP2.2

Technical Profile

What this product is

BENZIMIDAVIR is a chemical compound with CAS registry number 176161-24-3 and molecular formula C15H19Cl2N3O4 (molecular weight 376.2).

Identification

CAS number: 176161-24-3

Its molecular formula C15H19Cl2N3O4 comprises 15 C, 19 H, 2 Cl, 3 N, 4 O atoms.

Also known as: BENZIMIDAVIR · 苯并咪达韦

Frequently Asked Questions

What is the CAS number of BENZIMIDAVIR?

The CAS registry number of BENZIMIDAVIR is 176161-24-3.

What is the molecular formula and molecular weight of BENZIMIDAVIR?

Molecular formula C15H19Cl2N3O4, molecular weight 376.2.

What other names is BENZIMIDAVIR known by?

It is also registered under: BENZIMIDAVIR, 苯并咪达韦.

PubChem Public Data

Independent reference data for BENZIMIDAVIR (CAS 176161-24-3), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number176161-24-3
PubChem CID471161
Molecular formulaC15H19Cl2N3O4
IUPAC name(2S,3S,4R,5S)-2-[5,6-dichloro-2-(propan-2-ylamino)benzimidazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol
UNII (FDA)PTB4X93HE1

Computed descriptors

Molecular Weight376.2
XLogP32.2
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count6
Rotatable Bond Count4
Exact Mass375.0752615
Monoisotopic Mass375.0752615
Topological Polar Surface Area99.8
Heavy Atom Count24

Documented uses on record

    Maribavir is indicated for the treatment of post-transplant cytomegalovirus (CMV) infection (following hematopoietic stem cell transplant or solid organ transplant) which is refractory to standard treatment with [ganciclovir], [valganciclovir], [cidofovir], or [foscarnet]. In the US, patients receiving the treatment should weigh more than 35 kg and be at least 12 years old. In Canada and Europe, maribavir is only approved in adults.Maribavir is an orally available, antiviral agent which inhibits the pUL97 kinase of cytomegalovirus (CMV) and is used to treat refractory forms of post-transplant CMV infection. Maribavir has been associated with low rates of mild-to-moderate serum aminotransferase elevations during therapy but has not been linked to cases of clinically apparent acute liver injury.

    Synonyms and trade names

    Maribavir; 176161-24-3; Benzimidavir; livtencity; 1263W94; Camvia; maribavirum; BW-1263W94; GW-257406X; (2S,3S,4R,5S)-2-[5,6-dichloro-2-(propan-2-ylamino)benzimidazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol; GW-1263; PTB4X93HE1; BW 1263W94; 1263-W-94; DTXSID60170091; GW257406X

    GHS hazard classification

    Reported hazard statementsH302 (100%), H318 (50%), H371 (50%)

    H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

    H318 (50%): Causes serious eye damage [Danger Serious eye damage/eye irritation]

    What the public record says

    BENZIMIDAVIR · CAS 176161-24-3 · C15H19Cl2N3O4. UNII PTB4X93HE1.

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 苯并咪达韦

鲁ICP备19031700号-2